{"pub": "investingcom", "url": "https://in.investing.com/news/stock-market-news/briefglaxosmithkline-pharmaceuticals-recalls-zinetac-tablets-manufactured-in-india-1992523", "downloaded_at": "2019-09-25 13:42:21.186868+00:00", "title": "BRIEF-Glaxosmithkline Pharmaceuticals Recalls Zinetac Tablets Manufactured In India", "language": "en", "text": "BRIEF-Glaxosmithkline Pharmaceuticals Recalls Zinetac Tablets Manufactured In India\n\nStock Markets 12 minutes ago (Sep 25, 2019 19:00)\n\n\u00a9 Reuters. BRIEF-Glaxosmithkline Pharmaceuticals Recalls Zinetac Tablets Manufactured In India Sept 25 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd : * CONTACTED BY REGULATORY AUTHORITIES ABOUT DETECTION OF NDMA IN RANITIDINE PRODUCTS * SUSPENDS DISTRIBUTION OF ALL DOSE FORMS OF RANITIDINE HYDROCHLORIDE PRODUCTS TO ALL MARKETS * SUSPENSION AS A PRECAUTIONARY ACTION PENDING OUTCOME OF ONGOING TESTS AND INVESTIGATIONS * INITIATES VOLUNTARY RECALL OF ZINETAC TABLETS 150 MG AND 300 MG PRODUCTS MANUFACTURED IN INDIA * PRODUCT MANUFACTURED USING API FROM SMS LIFESCIENCES INDIA REMAIN ON HOLD, WILL NOT BE RELEASED WHILE CO AWAITS TEST RESULTS\n\nBRIEF-Glaxosmithkline Pharmaceuticals Recalls Zinetac Tablets Manufactured In India", "description": "BRIEF-Glaxosmithkline Pharmaceuticals Recalls Zinetac Tablets Manufactured In India", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB670Y6_L.jpg", "published_at": "2019-09-25"}